{"pmid":32273621,"title":"If a coronavirus vaccine arrives, can the world make enough?","text":["If a coronavirus vaccine arrives, can the world make enough?","Nature","Khamsi, Roxanne","32273621"],"journal":"Nature","authors":["Khamsi, Roxanne"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273621","week":"202015|Apr 06 - Apr 12","doi":"10.1038/d41586-020-01063-8","keywords":["SARS-CoV-2","Vaccines"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663712077906182144,"score":7.9164424,"similar":[{"pmid":32232474,"title":"Human challenge studies to accelerate coronavirus vaccine licensure.","text":["Human challenge studies to accelerate coronavirus vaccine licensure.","Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional Phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines available more quickly. Obviously, challenging volunteers with this live virus risks inducing severe disease and possibly even death. However, we argue that such studies, by accelerating vaccine evaluation, could reduce the global burden of coronavirus-related mortality and morbidity. Volunteers in such studies could autonomously authorize the risks to themselves, and their net risk could be acceptable if participants comprise healthy young adults, who are at relatively low risk of serious disease following natural infection, they have a high baseline risk of natural infection, and during the trial they receive frequent monitoring and, following any infection, the best available care.","J Infect Dis","Eyal, Nir","Lipsitch, Marc","Smith, Peter G","32232474"],"abstract":["Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional Phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines available more quickly. Obviously, challenging volunteers with this live virus risks inducing severe disease and possibly even death. However, we argue that such studies, by accelerating vaccine evaluation, could reduce the global burden of coronavirus-related mortality and morbidity. Volunteers in such studies could autonomously authorize the risks to themselves, and their net risk could be acceptable if participants comprise healthy young adults, who are at relatively low risk of serious disease following natural infection, they have a high baseline risk of natural infection, and during the trial they receive frequent monitoring and, following any infection, the best available care."],"journal":"J Infect Dis","authors":["Eyal, Nir","Lipsitch, Marc","Smith, Peter G"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232474","week":"202014|Mar 30 - Apr 05","doi":"10.1093/infdis/jiaa152","keywords":["Coronavirus","Ethics","Human Challenge Studies","Randomized Controlled Trials","Risk-Taking","Vaccines"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"_version_":1663352135427817472,"score":45.31088},{"pmid":32231319,"title":"'We need to be alert': Scientists fear second coronavirus wave as China's lockdowns ease.","text":["'We need to be alert': Scientists fear second coronavirus wave as China's lockdowns ease.","Nature","Cyranoski, David","32231319"],"journal":"Nature","authors":["Cyranoski, David"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32231319","week":"202014|Mar 30 - Apr 05","doi":"10.1038/d41586-020-00938-0","keywords":["Government","Infection","Vaccines"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1663352135414185984,"score":45.270424},{"pmid":32265540,"title":"Can the world's most influential climate report carry on?","text":["Can the world's most influential climate report carry on?","Nature","Tollefson, Jeff","32265540"],"journal":"Nature","authors":["Tollefson, Jeff"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265540","week":"202015|Apr 06 - Apr 12","doi":"10.1038/d41586-020-01047-8","keywords":["Climate sciences","Government","SARS-CoV-2"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663609715868827648,"score":44.912586},{"pmid":32194995,"pmcid":"PMC7060195","title":"The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines.","text":["The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines.","The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.","NPJ Vaccines","Shang, Weilong","Yang, Yi","Rao, Yifan","Rao, Xiancai","32194995"],"abstract":["The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2."],"journal":"NPJ Vaccines","authors":["Shang, Weilong","Yang, Yi","Rao, Yifan","Rao, Xiancai"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32194995","week":"202012|Mar 16 - Mar 22","doi":"10.1038/s41541-020-0170-0","keywords":["Infection","Microbiology","Pathogenesis","Vaccines"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352133456494592,"score":44.1402},{"pmid":32203360,"title":"What China's coronavirus response can teach the rest of the world.","text":["What China's coronavirus response can teach the rest of the world.","Nature","Cyranoski, David","32203360"],"journal":"Nature","authors":["Cyranoski, David"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32203360","week":"202013|Mar 23 - Mar 29","doi":"10.1038/d41586-020-00741-x","keywords":["Government","Infection","Public health"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1663352133657821185,"score":40.832676}]}